Abstract

The insufficient effects associated with current treatment regimens require the use of novel therapeutic formulations for acne vulgaris. Consequently, this study was undertaken to develop triclosan nanogels of poly(N-isopropylacrylamide) having a thermoresponsive character prepared by surfactant-free emulsion polymerization in the presence of N,N′ methylenebisacrylamide crosslinker. The particle size, zeta potential, thermal analysis, drug loading, swelling capacity, morphological analysis, ex-vivo diffusion, rheological characterization, and the antibacterial potential against causing C. acnes were evaluated. It was observed that the swelling capacity of nanogel formulations increased when triclosan and ethanol were added. All nanogel formulations performed a viscoelastic behaviour at 25 °C and the elastic modulus G′ was higher at 25 °C compared to 37 °C. The results showed that G′ values increased with increasing concentration of hydrophilic monomers. The encapsulation efficiency was obtained as 47.4% and 63.7%. The antibacterial potency of nanogel formulation against C. acnes surpassed the commercial product used as the positive control. According to the study, TCS nanogels of poly(N-isopropylacrylamide) with size and rheological behaviour were found to be suitable for dermal applications. The potent antibacterial activity in thermoresponsive nanogel formulation could be an alternative to existing conventional formulations in the treatment of acne vulgaris.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.